.
New Delhi, April 21 (MondayMirror.com) The expert panel of India’s apex drug regulator on Thursday recommended grant of emergency use authorisation to Covid vaccine Corbevax for those in the 5-12 years age bracket.
According to a source familiar with the development, the Subject Expert Committee has recommended Drug Controller General of India grant the emergency use authorisation to Hyderabad-based Biological E’s Corbevax for this age. However, the emergency use authorisation may be the subject of certain conditions, the source added.
Earlier in the day, the panel held a meeting to discuss the recommendations on restricted emergency use of Bharat Biotech’s Covaxin and Biological E’s Corbevax vaccines among children aged 5-12.
The SEC has sent the recommendations to the DCGI. After the DCGI’s nod to the recommendation, the Union Health Ministry may give final approval to begin the vaccination for this age group.
Corbevax vaccine is India’s first indigenously-developed protein sub-unit vaccine against Covid-19. This vaccine is currently being administered to children in the age group 12-14 years.
Source: IANS
Small Wonders School, Mohali, celebrated its Annual Day with enthusiasm and vibrant performances under the…
Velvet Clarks Exotica, Zirakpur celebrated its 12th Annual Day with great enthusiasm, joy, and team…
Artificial Intelligence (AI) must serve as a tool to enhance human intelligence rather than replace…
“My main objective is to empower needy women by training them in crafts like hand…
Their publication received the 2026 Best Case Report – Silver Award at Plastic Surgery The…
Michael Jackson's extraordinary musical legacy is returning to the spotlight, but this time, the conversation…